Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities Post published:May 3, 2021 Post category:Press Release
Champignon Brands Announces Revocation of Cease Trade Orders Post published:April 22, 2021 Post category:Press Release
Champignon Brands Announces Filing of Listing Statement Post published:March 26, 2021 Post category:Press Release
Champignon Brands to Restate Financial Statements and MD&A has Prepared CSE Listing Statement Post published:February 17, 2021 Post category:Press Release
Dr. Roger McIntyre Announces Changes to the Board of Champignon Brands Inc. Post published:February 4, 2021 Post category:Press Release
Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression Post published:January 25, 2021 Post category:Press Release
Champignon Brands Announces New CFO and New General Counsel Post published:January 11, 2021 Post category:Press Release
Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life Post published:January 8, 2021 Post category:Press Release
Champignon Brands Appoints Christopher Hobbs as Interim Chief Financial Officer Post published:December 8, 2020 Post category:Press Release
Champignon Brands Updates Investors on Changes at the Top Post published:November 24, 2020 Post category:Press Release